Migraine.

Physical medicine and rehabilitation clinics of North America 2025 Vol.36(4) p. 701-714

Chen HH, Heath KM, Patel PR

관련 도메인

Abstract

Migraine, a common primary headache disorder, ranks second only to low back pain as a leading cause of disability. Proposed mechanisms include vasodilation, trigeminovascular activation, and neurogenic inflammation. Diagnosis is clinical, as no biomarker exists, and the International Classification of Headache Disorders-3 has clinical criteria for diagnosis. Differentiating migraine from other conditions can be challenging, with "red" and "green flags" guiding assessment. Treatment includes acute and preventive options, with calcitonin gene-related peptide inhibitors and neuromodulation as newer strategies. Complementary therapies and botulinum toxin injections may also benefit those with chronic migraine.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 1
해부 back scispacy 1
해부 trigeminovascular scispacy 1
약물 calcitonin gene-related peptide inhibitors C0006669
Calcitonin Gene-Related Peptide
scispacy 1
약물 green scispacy 1
질환 Migraine C0149931
Migraine Disorders
scispacy 1
질환 primary headache disorder C1565106
Headache Disorders, Primary
scispacy 1
질환 low back pain C0024031
Low Back Pain
scispacy 1
질환 disability C0231170
Disability
scispacy 1
질환 neurogenic inflammation C0600467
Neurogenic Inflammation
scispacy 1
질환 Headache C0018681
Headache
scispacy 1
기타 calcitonin gene-related scispacy 1

MeSH Terms

Humans; Migraine Disorders

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문